Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
Yaariv Khaykin, Associate Professor at University of Toronto, shared on LinkedIn about a recent article by Masamichi Yano et al, published in Journal of Arrhythmia, adding:
”We talk a lot about anticoagulation and ablation for AF stroke prevention — but what about the modifiable lifestyle factors that drive thromboembolic risk in the first place?
A large multicenter study from Japan (over 26,000 AF patients) examined smoking and alcohol consumption as independent predictors of cardioembolic stroke.
The findings reinforce something I think we underemphasize in clinic:
Current smoking was independently associated with stroke across nearly every age group. Daily alcohol intake was associated with stroke in patients 75 and under.
And here’s the nuance — as patients age, their CHA2DS2-VASc scores climb through accumulating comorbidities, while smoking and drinking prevalence actually decline. So in younger AF patients, lifestyle factors may represent a proportionally larger share of modifiable risk.
What does this mean practically?
When I see a 55-year-old with new AF, a CHA2DS2-VASc of 2, who smokes and drinks daily — the conversation isn’t just ‘should we anticoagulate?’ It’s also ‘what can we change about the inputs driving your risk higher every year?’
We tend to treat the score as fixed. But smoking cessation, alcohol reduction, weight management, and exercise aren’t just general wellness advice — they’re stroke prevention strategies in AF patients.
They’re complementary to whatever procedural or pharmacologic intervention we choose, whether that’s anticoagulation, ablation, or appendage closure.
The whole-person approach isn’t a luxury add-on.
For many of our patients, it’s where the biggest gains are hiding.”
Title: Lifestyle Factors and Thromboembolic Risk in Atrial Fibrillation: Age-Dependent Effects of Smoking and Alcohol Consumption
Authors: Masamichi Yano, Yasuyuki Egami, Mikako Kise, Taichi Mukai, Noriyuki Kobayashi, Ayako Sugino, Masaru Abe, Hiroaki Nohara, Shodai Kawanami, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga-Lee, Masami Nishino
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026